|
9th Influenza Conference 2023
The Influenza B/Yamagata lineage appears to become extinct: implications for quadrivalent influenza vaccines?
SPI08 session from #ESWI2023
|
9th Influenza Conference 2023
Meet the first winners of ESWIs Diversity Equity and Inclusion Award
ESWI is pleased to announce the five winners of the Award in Recognition of Diversity Equity and Inclusion.
|
9th Influenza Conference 2023
Meet the winner of the Young Scientist Vaccine Innovation Award: Jenna Guthmiller
Jenna Guthmiller, Assistant Professor at the University of Colorado Anschutz, has been selected as the third recipient of the Early Career Scientist Vaccine Innovation Award, for her innovative work around vaccination and immunity.
|
9th Influenza Conference 2023
Meet the winner of the Claude Hannoun prize for Best Body of Work: Carolien van de Sandt
The seventh edition of Claude Hannoun Prize for Best Body of Work goes to Carolien van de Sandt, Peter Doherty Institute, University of Melbourne (Australia)...
|
9th Influenza Conference 2023
Communication: Raising awareness on the burden of disease
Scientific communication is critical for promoting scientific literacy and facilitating informed decision-making among the public.
|
9th Influenza Conference 2023
Next on the Influenza Virus Vaccine Horizon: A Slow Releasing Antigen Concept
Mimicking vaccine delivery kinetics of natural infection: extending the delivery of influenza virus antigens
|
9th Influenza Conference 2023
Global health perspectives on acute respiratory virus disease and how to ensure an equitable response/access to vaccines and therapy
SPI04 session from #ESWI2023
WHO welcomes historic commitment by world leaders for greater collaboration, governance and investment to prevent, prepare for and respond to future pandemics
“The first-ever head of state summit on pandemic prevention, preparedness and response is a historic milestone in the urgent drive to make all people of the world safer, and better protected from the devastating impacts of pandemics,” said Dr Tedros
|
9th Influenza Conference 2023
Increasing Influenza vaccination uptake among children aged 2-17 years old in Ireland: A new initiative deployed mid-season
POSTER 436 from #ESWI2023
|
9th Influenza Conference 2023
Studying the impact of NS1 on host tropism of influenza A virus
POSTER 632 from #ESWI2023
|
9th Influenza Conference 2023
Neuraminidase-dependent entry of influenza A virus is determined by haemagglutinin receptor- binding activity
